SwiftMR® by AIRS Medical Gains FDA Clearance for Use with OEM Deep Learning MRI Solutionsnews2026-04-15T13:28:15+00:00April 15th, 2026|Medical Device News Magazine|
Updated: FDA asks for data on Lilly’s Foundayo to assess heart, liver risksnews2026-04-14T17:50:20+00:00April 14th, 2026|Endpoints News|
Replimune looks ahead as repeat CRL speeds the company’s declinenews2026-04-14T17:19:37+00:00April 14th, 2026|Endpoints News|
FDA approves Travere’s Filspari as first drug for the kidney disease FSGSnews2026-04-14T09:02:09+00:00April 14th, 2026|Endpoints News|
FDA narrows in on search for new biologics and vaccines leadernews2026-04-13T17:35:19+00:00April 13th, 2026|Endpoints News|
FDA rejects Replimune cancer therapy, saying company didn’t resolve trial doubtsnews2026-04-10T16:16:03+00:00April 10th, 2026|Endpoints News|
FDA plans another safety study of abortion drug after court ordernews2026-04-09T18:29:48+00:00April 9th, 2026|Endpoints News|
Proposed FDA budget sets Makary up to boost US biotechnews2026-04-06T18:38:19+00:00April 6th, 2026|Endpoints News|
Gilead ends a Phase 2/3 trial of long-acting HIV pillsnews2026-04-01T23:18:50+00:00April 1st, 2026|Endpoints News|
Noom plans push into peptides beyond weight loss drugsnews2026-04-01T20:47:39+00:00April 1st, 2026|Endpoints News|
